In-office diabetes testing

The DCA® HbA1c test kit, used for more than two decades to monitor patients, can now be used as an aid to diagnose diabetes and identify patients at risk for developing the disease. The dual use kit, for both monitoring and diagnosing, is available for sale in EU countries and countries not requiring any local regulatory clearances under part #10698915. Early detection and tight glycemic control help mitigate the serious conditions that accompany diabetes: heart and kidney disease, limb neuropathy, retinopathy, and stroke. More importantly, patients identified as being at risk can stop or reverse disease progression through lifestyle adjustments and/or pharmacological treatment. Availability of results at the time of visit provides healthcare providers and educators the opportunity to have meaningful, faceto- face discussions regarding treatment options. From a convenience and scheduling standpoint, it eliminates multiple visits for pre-visit blood draws or post-testing follow-up consultation. The DCA Vantage® analyser is just one of two point-of-care HbA1c analysers that meet NGSP performance criteria.

Supplier: Siemens Healthineers

Mail the supplier